PTP1B inhibitors (University of Pittsburgh)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePTP1B inhibitors (University of Pittsburgh)
Drug Alias NameFY21-alpha alpha 09FY3-alphaalpha09FY21-alphaalpha09
ClassificationSmall molecules
Mechanisms of ActionProtein tyrosine phosphatase inhibitors
TargetsProtein tyrosine phosphatase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Pittsburgh
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A